Literature DB >> 32116194

The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online.

Caroline Zangani1, Fabrizio Schifano2, Flavia Napoletano3, Davide Arillotta4, Liam Gilgar5, Amira Guirguis6, John M Corkery2, Orsola Gambini1, Alessandro Vento7.   

Abstract

BACKGROUND: A wide range of novel psychoactive substances (NPS) is regularly searched and discussed online by web-based drug enthusiasts (i.e. the e-psychonauts). Among NPS, the range of synthetic cannabinoids (SC; 'Spice') currently represents a challenge for governments and clinicians.
METHODS: Using a web crawler (i.e. the NPS.Finder®), the present study aimed at assessing psychonauts' fora/platforms to better understand the online mentions of SC.
RESULTS: The open-web crawling/navigating software identified here some 1,103 synthetic cannabinoids. Of these, 863 molecules were not listed in either the international or the European NPS databases.
CONCLUSION: A web crawling approach helped here in identifying a large range of unknown SC likely to possess a misuse potential. Most of these novel/emerging molecules are still relatively unknown. This is a reason for concern; each of these analogues potentially presents different toxicodynamic profiles and there is a lack of docking, preclinical, and clinical observations. Strengthening multidisciplinary collaboration between clinicians and bioinformatics may prove useful in better assessing SC-associated public health risks. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  NPS; Psychonauts; new psychoactive substances; synthetic cannabinoids; web crawling

Mesh:

Substances:

Year:  2020        PMID: 32116194      PMCID: PMC7709145          DOI: 10.2174/1570159X18666200302125146

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


  35 in total

1.  Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey.

Authors:  Pierluigi Simonato; Ornella Corazza; Paolo Santonastaso; John Corkery; Paolo Deluca; Zoe Davey; Ursula Blaszko; Fabrizio Schifano
Journal:  Hum Psychopharmacol       Date:  2013-07       Impact factor: 1.672

2.  Two thiazolylindoles and a benzimidazole: novel compounds on the designer drug market with potential cannabinoid receptor activity.

Authors:  Folker Westphal; Frank D Sönnichsen; Siegfried Knecht; Volker Auwärter; Laura Huppertz
Journal:  Forensic Sci Int       Date:  2015-01-29       Impact factor: 2.395

3.  Exploring the "like" in the psychological interaction of users on fan community: A netnography analysis.

Authors:  Yi-Sheng Wang
Journal:  J Community Psychol       Date:  2019-04-24

4.  Toxicology in international drug control-Prioritizing the most harmful, persistent and prevalent substances.

Authors:  Susan C Ifeagwu; Martin Raithelhuber; Conor Crean; Dimitri Gerostamoulos; Heesun Chung; Justice N Tettey
Journal:  Forensic Sci Int       Date:  2016-11-20       Impact factor: 2.395

5.  e-Psychonauts: conducting research in online drug forum communities.

Authors:  Zoe Davey; Fabrizio Schifano; Ornella Corazza; Paolo Deluca
Journal:  J Ment Health       Date:  2012-08

6.  Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.

Authors:  Stephen L Thornton; Jean Lo; Richard F Clark; Alan H B Wu; Roy R Gerona
Journal:  Clin Toxicol (Phila)       Date:  2012-11-20       Impact factor: 4.467

7.  The ChEMBL database in 2017.

Authors:  Anna Gaulton; Anne Hersey; Michał Nowotka; A Patrícia Bento; Jon Chambers; David Mendez; Prudence Mutowo; Francis Atkinson; Louisa J Bellis; Elena Cibrián-Uhalte; Mark Davies; Nathan Dedman; Anneli Karlsson; María Paula Magariños; John P Overington; George Papadatos; Ines Smit; Andrew R Leach
Journal:  Nucleic Acids Res       Date:  2016-11-28       Impact factor: 16.971

8.  Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking.

Authors:  Christopher R Ellis; Naomi L Kruhlak; Marlene T Kim; Edward G Hawkins; Lidiya Stavitskaya
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

9.  Editorial: Novel Psychoactive Drugs.

Authors:  Liana Fattore; Aviv M Weinstein
Journal:  Front Psychiatry       Date:  2019-03-11       Impact factor: 4.157

10.  Synthetic Cannabinoid use in a Case Series of Patients with Psychosis Presenting to Acute Psychiatric Settings: Clinical Presentation and Management Issues.

Authors:  Stefania Bonaccorso; Antonio Metastasio; Angelo Ricciardi; Neil Stewart; Leila Jamal; Naasir-Ud-Dinn Rujully; Christos Theleritis; Stefano Ferracuti; Giuseppe Ducci; Fabrizio Schifano
Journal:  Brain Sci       Date:  2018-07-14
View more
  3 in total

1.  Novel Δ8-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals.

Authors:  Jiries Meehan-Atrash; Irfan Rahman
Journal:  Chem Res Toxicol       Date:  2021-12-10       Impact factor: 3.739

2.  Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach.

Authors:  Valeria Catalani; Davide Arillotta; John Martin Corkery; Amira Guirguis; Alessandro Vento; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

3.  Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives.

Authors:  Davide Radaelli; Alessandro Manfredi; Martina Zanon; Paolo Fattorini; Matteo Scopetti; Margherita Neri; Paolo Frisoni; Stefano D'Errico
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.